drugset / Trial / NCT05001204

68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor

NCT05001204 ↗

Phase 0 Unknown 30 enrolled Peking Union Medical College Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-RM26 in Gastrointestinal stromal tumor(GIST)patients. A single dose of 55.5 to 148 MBq(1.5-4 mCi) of 68Ga-NOTA-RM26 will be injected intravenously. Patients underwent whole-body PET/CT scans at 30-90 minutes after intravenous injection.

Timeline

Start
2021-05-01
Primary completion
2022-08-31
Completion
2022-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-NOTA-RM26 Diagnostic / imaging agent 55.5 mbq Intravenous
Subject 68Ga-NOTA-RM26 Diagnostic / imaging agent 148 mbq Intravenous